Skip to content
Intrommune Therapeutics
  • About Us
  • Our Science
    • Overview
    • Multifood INT302
  • News & Resources
  • Blog
  • Contact
Intrommune Therapeutics

Intrommune

Senior Medical Advisor, William Reisacher, interviewed on the Price of Business with Kevin Price

In the News / By Intrommune

Survey Confirms Physician Interest in Peanut Allergy Immunotherapy

Press Releases / By Intrommune

Proactive Interview: Intrommune Therapeutics moving its peanut allergy treatment through the FDA approval process

In the News / By Intrommune

Intrommune Presenting at Biotech Showcase 2020

Press Releases / By Intrommune

Biotech Showcase™ 2020

Events / By Intrommune

Food Allergy Fund Summit

Events / By Intrommune

Providing Innovative Treatments for Peanut Allergies Intrommune CEO, Michael Nelson, interview on the Price of Business with Kevin Price

In the News / By Intrommune

Science News: Liquid mouth drops could one day protect people from peanut allergies

In the News / By Intrommune

PCCI Bridgewater Meeting

Events / By Intrommune

Intrommune Therapeutics selected as one of the RESI NYC Innovation Challenge Finalists

In the News / By Intrommune
Posts pagination
← Previous Page 1 … 6 7 8 Next Page →
  • About Us
  • Our Science
    • Overview
    • Multifood INT302
  • News & Resources
  • Blog
  • Contact
  • About Us
  • Our Science
  • Multifood INT302
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Intrommune
  • About Us
  • Our Science
  • Multifood INT302
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Copyright © 2025 Intrommune Therapeutics | Privacy Policy | Accessibility Statement